Table 1.
Key parameter inputs to simulation model.
Table 2.
Cost and utility parameters.
Table 3.
Mean cost, QALYs, and infections per 10,000 patient days by BASE, INT, and OPT.
Table 4.
Results from cost-effectiveness analysis.
Fig 1.
Scatterplot of incremental cost and effectiveness (C. difficile infections averted) of intervention strategies compared with BASE levels of all 6 bundle components.
HAND: light gray = BASE, dark gray = INT, black = OPT; DCON: circle = BASE, triangle = INT, square = OPT; ISOL: hollow = BASE, filled = INT.
Fig 2.
Scatterplot of incremental cost and effectiveness (C. difficile infections averted) of intervention strategies compared with INT levels of all 6 bundle components.
HAND: dark gray = INT, black = OPT; DCON: triangle = INT, square = OPT.
Fig 3.
Cost-effectiveness acceptability curves depicting the probability that BASE, INT, and OPT strategies are cost-effective across different threshold values of willingness to pay from 195 2nd order Monte Carlo simulations.